Tactile Medical Acquires Intellectual Property Rights Related to Pneumatic Compression Device Technology
Summary
“We are pleased to expand our intellectual property portfolio with the addition of Wright Therapy Products’ innovative patents for pneumatic compression device technology,” said Gerald R. Mattys, Chief Executive Officer of Tactile Medical.“The addition of these patents further strengthens our position as a leading provider of clinically effective, at-home therapies for the treatment of lymphedema and other chronic swelling conditions.”The Company’s unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates and clinicians.Tactile Medical takes pride in the fact that our solutions help increase clinical efficacy, reduce overall healthcare costs and improve the quality of life for patients with chronic conditions.The reader is cautioned not to put undue reliance on these forward looking statements, as these statements are subject to numerous factors and uncertainties outside of the Company’s control that can make such statements untrue, including, but not limited to, the adequacy of the Company’s liquidity to pursue its complete business objectives; the Company’s ability to obtain reimbursement from third party payers for its products; loss or retirement of key executives; adverse economic conditions or intense competition; loss of a key supplier; entry of new competitors and products; adverse federal, state and local government regulation; technological obsolescence of the Company’s products; technical problems with the Company’s research and products; the Company’s ability to expand its business through strategic acquisitions; the Company’s ability to integrate acquisitions and related businesses; price increases for supplies and components; or the inability to carry out research, development and commercialization plans.